© 2021 MJH Life Sciences™ and Managed Healthcare Executive. All rights reserved.
All News
The Controversy Over Omega-3 Fatty Acids
A failed trial at the American Heart Association leads to pointed fingers at game-changing research on Vascepa, and counter claims of "manufactured controversy."
Key Takeaways for Managed Care Organizations as No Surprises Act Goes Into Effect
November 26, 2021
The No Surprises Act is scheduled to go into effect in January. The law will require providers to provide patients with details of the new balance billing requirements, any state-level limitations or prohibitions in the state of service, and the dispute resolution process.
Study: COVID-19 Can Cause Cognitive Effects
November 25, 2021
New research confirms that regardless of age or severity of COVID-19 infection, prolonged effects on cognitive function are possible.
Reasons for Aduhelm’s $56,000 Price Tag
November 25, 2021
The $56,000 price tag is a rational response to an irrational insurance system, says a Berkeley Public Health economist in an opinion piece in this week’s New England Journal of Medicine.
Implementing Wellness Programs For Employers and Health Plans per Neepa Patel of WellRight
November 24, 2021
Briana Contreras, associate editor of Managed Healthcare Executive spoke with WellRight CEO, Neepa Patel, on the topic of wellness programs in healthcare and the need for employers and health plans to roll out new, effective, holistic and innovative programs for patients. Patel did discuss the challenges that some organization can face when rolling out these programs, but she explained how accessible, affordable and beneficial these programs are for patients mental health and wellbeing.
Why 50/50 Gender Representation Matters in Healthcare
November 24, 2021
When women are underrepresented in healthcare — half of our world’s population becomes at-risk.
It's Time to Rethink Respiratory Virus Transmission and How To Prevent It in Healthcare Settings
November 24, 2021
The traditional dividing line between transmission by droplets and smaller aerosols is incorrect, say the authors of a Annals of Internal Medicine review paper, and infection control measures need to reflect the new understanding that respiratory viruses spread in respiratory particles of all sizes and perhaps mainly in aerosols.
How Precision Medicine and Genetic Testing Will Drive Value-based Care
November 23, 2021
The shift to value-based care in the U.S. has been slow in coming, in large part because providers have continued to cling to the traditional “fee for service” healthcare model that historically has worked well for them.
Healthcare Provisions in the House Version of Build Back Better
November 23, 2021
Two key health provisions in the House “BBB “ would empower CMS to negotiate the prices of 10 drugs starting in 2023 and put a limit of $2,000 on Medicare Part D annual out-of-pocket costs.
Employees are Looking in to new Benefits During Enrollment Season
November 22, 2021
U.S. workers plan to spend more time reviewing their healthcare options and enrolling in new benefits during this enrollment period
What’s Next for the Biosimilars Market in the U.S.?
November 22, 2021
Momentum is building for biosimialrs but robust coverage for lower-cost agents, including biosimilars, is needed.